SESSION I

Histopathology and biology

Histology
E. Sabattini
Molecular predictors
H.G. Wendel
SESSION II

Front line therapy - How I approach

Lecture

POD24 today
C. Flowers
SESSION III

CAR-T, update clinical trials and RWE

Lisocel
L. Palomba
SESSION IV

BISPECIFICS, update clinical trials and potential combinations

Mosunetuzumab
L.H. Sehn
SESSION V

New agents

Golcadomide
J.M. Michot
Tazemetostat
V. Ribrag